Lan‐Ping Xu

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

Yu Wang, Qifa Liu, Lan‐Ping Xu et al. · Blood · 2015 · 492 citations · Full text

Medicine, Hematology, Oncology +14

Who is the best donor for a related HLA haplotype-mismatched transplant?

Yu Wang, Ying‐Jun Chang, Lan‐Ping Xu et al. · Blood · 2014 · 354 citations · Full text

Life Sciences, Hematology, Immunology +14

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Hong‐Hu Zhu, Xiaohui Zhang, Ya‐Zhen Qin et al. · Blood · 2013 · 324 citations · Full text

Medicine, Oncology, Outcomes Research +7

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

Xiaohui Zhang, Jing Chen, Mingzhe Han et al. · Journal of Hematology & Oncology · 2021 · 305 citations · Full text

Medicine, Hematology, Immunology +15

Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation

Xiao‐Jun Huang, Dai‐Hong Liu, Kai‐Yan Liu et al. · Biology of Blood and Marrow Transplantation · 2009 · 295 citations · Full text

Medicine, Hematology, Immunology +17